Covid-19 roundup: Yet more doses of the AstraZeneca-Oxford vaccine; A second randomized hydroxychloroquine study fails
Another gene therapy company is offering its facilities to the Covid-19 fight.
Oxford Biomedica, a 90s-era spinout of Oxford University, has signed a 5-year agreement to help manufacture the Covid-19 vaccine being developed by Oxford University’s Jenner Institute and AstraZeneca. The deal is with the Vaccines Manufacturing and Innovation Centre, a government-sponsored non-profit set up 2 years ago to shore up the isle’s vaccine manufacturing capacity.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.